FARMACIA Y SALUD
PhD school
University of Milano-Bicocca
Milán, ItaliaPublications in collaboration with researchers from University of Milano-Bicocca (1)
2024
-
Comparison between tofacitinib and ustekinumab as a third-line therapy in refractory ulcerative colitis: A multicenter international study
United European Gastroenterology Journal